Adial Pharmaceuticals Inc (ADIL)
1.645
-0.08
(-4.91%)
USD |
NASDAQ |
Apr 26, 13:58
Adial Pharmaceuticals Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2021 | -0.034M |
| September 30, 2021 | -0.384M |
| June 30, 2021 | -0.384M |
| March 31, 2021 | -0.3503M |
| December 31, 2020 | -0.35M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 |
| Date | Value |
|---|---|
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 0.0351M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.384M
Minimum
Jun 2021
-0.034M
Maximum
Dec 2021
-0.3005M
Average
-0.3503M
Median
Mar 2021
Cash from Investing (TTM) Benchmarks
| BioVie Inc | 0.2239M |
| BioSig Technologies Inc | -0.186M |
| Precision BioSciences Inc | 5.829M |
| Humacyte Inc | -0.173M |
| Monogram Orthopaedics Inc | -0.0649M |